GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » Cyclically Adjusted PS Ratio

IM Cannabis (IM Cannabis) Cyclically Adjusted PS Ratio : 0.08 (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is IM Cannabis Cyclically Adjusted PS Ratio?

As of today (2024-04-30), IM Cannabis's current share price is $0.56. IM Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $7.12. IM Cannabis's Cyclically Adjusted PS Ratio for today is 0.08.

The historical rank and industry rank for IM Cannabis's Cyclically Adjusted PS Ratio or its related term are showing as below:

IMCC' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.03   Med: 3.53   Max: 32.11
Current: 0.08

During the past years, IM Cannabis's highest Cyclically Adjusted PS Ratio was 32.11. The lowest was 0.03. And the median was 3.53.

IMCC's Cyclically Adjusted PS Ratio is ranked better than
96.75% of 739 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs IMCC: 0.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IM Cannabis's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.477. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $7.12 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


IM Cannabis Cyclically Adjusted PS Ratio Historical Data

The historical data trend for IM Cannabis's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Cyclically Adjusted PS Ratio Chart

IM Cannabis Annual Data
Trend Apr13 Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 21.54 6.99 0.14 0.05

IM Cannabis Quarterly Data
Jan19 Apr19 Jul19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.11 0.14 0.10 0.05

Competitive Comparison of IM Cannabis's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Cyclically Adjusted PS Ratio falls into.



IM Cannabis Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

IM Cannabis's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.56/7.12
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IM Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, IM Cannabis's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.477/129.4194*129.4194
=2.477

Current CPI (Dec. 2023) = 129.4194.

IM Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201210 0.000 97.595 0.000
201301 0.000 97.158 0.000
201304 0.000 98.107 0.000
201307 0.000 98.557 0.000
201310 0.000 98.536 0.000
201401 0.000 98.692 0.000
201404 0.000 100.023 0.000
201407 0.000 100.520 0.000
201410 0.000 100.176 0.000
201501 0.000 98.604 0.000
201604 0.000 100.947 0.000
201607 0.000 101.524 0.000
201610 0.000 101.988 0.000
201701 0.000 102.456 0.000
201704 0.000 103.167 0.000
201707 0.000 103.278 0.000
201710 0.000 104.070 0.000
201801 0.000 104.578 0.000
201804 0.000 105.708 0.000
201807 0.000 106.324 0.000
201901 0.000 106.200 0.000
201904 0.000 107.818 0.000
201907 0.000 108.250 0.000
201912 0.000 108.420 0.000
202003 0.263 108.902 0.313
202006 0.739 108.767 0.879
202009 1.545 109.815 1.821
202012 0.962 109.897 1.133
202103 1.703 111.754 1.972
202106 1.787 114.631 2.018
202109 0.887 115.734 0.992
202112 1.135 117.630 1.249
202203 1.474 121.301 1.573
202206 1.423 125.017 1.473
202209 4.008 125.227 4.142
202212 3.906 125.222 4.037
202303 0.935 127.348 0.950
202306 0.697 128.729 0.701
202309 2.223 129.860 2.215
202312 2.477 129.419 2.477

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IM Cannabis  (NAS:IMCC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


IM Cannabis Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IM Cannabis (IM Cannabis) Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.